Photronics Q2 Earnings Confirm Operational Decline, Margins Contract; Omits Recent Securities Investigation
PLAB sits 66% above its 52-week low of $18.
Summary
Photronics reported a Q2 FY26 operational slowdown with declining revenue and margins, confirming a prior miss. The filing notably omits any mention of a recent securities law investigation, raising transparency concerns.
Key Events · Earnings and Guidance · PLAB
-
Q2 FY26 Revenue Decline
Revenue for Q2 FY26 was $209.9 million, a 6.7% decrease from Q1 FY26 and a 0.5% decrease year-over-year, primarily due to lower demand in the IC business.
-
Gross Margin Contraction
Gross margin fell to 31.3% in Q2 FY26 from 35.0% in Q1 FY26 and 36.9% in Q2 FY25, attributed to an unfavorable product mix and increased labor, material, and manufacturing costs.
-
Operational Profitability Weakens
Operating income decreased by 23.1% sequentially from Q1 FY26 and 24.3% year-over-year from Q2 FY25, reflecting the broader operational slowdown.
-
EPS Decline Sequentially, Boosted by FX Year-over-Year
Diluted EPS was $0.54, down from $0.74 in Q1 FY26. The year-over-year increase from $0.15 in Q2 FY25 was significantly influenced by a $7.9 million foreign currency transaction gain in Q2 FY26, contrasting with a $31.1 million loss in the prior year period.
Analysis · PLAB · Manufacturing
Photronics' Q2 FY26 results confirm the previously announced earnings and revenue miss, showing a significant sequential operational decline. Revenue decreased 6.7% from Q1 FY26, while gross margin contracted from 35.0% to 31.3% due to unfavorable product mix and higher costs. Operating income and diluted EPS also saw substantial sequential drops. Although year-over-year net income and EPS improved, this was largely driven by a favorable swing in foreign currency transactions (a $7.9 million gain in Q2 FY26 compared to a $31.1 million loss in Q2 FY25). Critically, the company's legal disclosures state that no material changes to risk factors occurred and that ordinary course claims will not have a material effect, despite a Hagens Berman securities law investigation being publicly announced on June 4, 2026, prior to this 10-Q's filing date. This omission raises significant concerns about transparency and potential legal risks.
At the time of this filing, PLAB was trading at $29.95 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $18.00 to $56.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.